Deccan Health Care Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	847.12	750.58	597.29	450.22	331.71	337.76
Revenue Growth (YoY)	29.94%	25.66%	32.67%	35.73%	-1.79%	-20.05%
Cost of Revenue	556.34	475.86	375.72	250.18	144.83	186.91
Gross Profit	290.78	274.72	221.57	200.04	186.88	150.85
Selling, General & Admin	51.42	45.42	36.24	33.79	21.95	29.18
Other Operating Expenses	202.82	197.79	147.82	146.63	107.29	101.06
Operating Expenses	268.83	257.74	198.73	194.69	143.97	144.89
Operating Income	21.95	16.99	22.84	5.35	42.91	5.96
Interest Expense	-1.97	-0.58	-0.56	-0.86	-1.13	-0.76
Interest & Investment Income	0.01	0.01	0.14	0.16	0.04	0.08
Other Non Operating Income (Expenses)	-0.05	-0.12	-0.28	-0.26	0.44	-0.08
EBT Excluding Unusual Items	19.94	16.3	22.14	4.4	42.26	5.19
Gain (Loss) on Sale of Assets	-	-	-	-	-2.84	-
Other Unusual Items	-	-	-	-	-34	-
Pretax Income	19.94	16.3	22.14	4.4	5.43	5.19
Income Tax Expense	5.75	4.72	7.21	1.34	2.2	1.29
Net Income	14.19	11.59	14.93	3.06	3.23	3.9
Net Income to Common	14.19	11.59	14.93	3.06	3.23	3.9
Net Income Growth	-8.12%	-22.37%	387.62%	-5.12%	-17.26%	-96.14%
Shares Outstanding (Basic)	23	22	19	13	16	16
Shares Outstanding (Diluted)	25	26	19	13	16	16
Shares Change (YoY)	10.95%	38.37%	45.91%	-18.83%	-	-
EPS (Basic)	0.61	0.54	0.80	0.24	0.21	0.25
EPS (Diluted)	0.56	0.45	0.80	0.24	0.21	0.25
EPS Growth	-16.98%	-43.75%	233.33%	16.90%	-17.26%	-96.14%
Free Cash Flow	-95.37	-67.47	-127.92	-67.65	-6.85	0.61
Free Cash Flow Per Share	-3.77	-2.62	-6.87	-5.30	-0.44	0.04
Gross Margin	34.33%	36.60%	37.10%	44.43%	56.34%	44.66%
Operating Margin	2.59%	2.26%	3.82%	1.19%	12.93%	1.76%
Profit Margin	1.68%	1.54%	2.50%	0.68%	0.97%	1.15%
Free Cash Flow Margin	-11.26%	-8.99%	-21.42%	-15.02%	-2.07%	0.18%
EBITDA	36.54	31.51	37.51	19.62	57.63	20.62
EBITDA Margin	4.31%	4.20%	6.28%	4.36%	17.37%	6.11%
D&A For EBITDA	14.59	14.53	14.67	14.28	14.73	14.66
EBIT	21.95	16.99	22.84	5.35	42.91	5.96
EBIT Margin	2.59%	2.26%	3.82%	1.19%	12.93%	1.76%
Effective Tax Rate	28.82%	28.92%	32.58%	30.38%	40.53%	24.89%
Revenue as Reported	847.24	750.64	597.44	450.41	333.92	338.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.